Osaic Holdings Inc. Has $8.02 Million Stock Position in Agilent Technologies, Inc. $A

Osaic Holdings Inc. grew its holdings in Agilent Technologies, Inc. (NYSE:A) by 35.5% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 68,053 shares of the medical research company’s stock after purchasing an additional 17,817 shares during the period. Osaic Holdings Inc.’s holdings in Agilent Technologies were worth $8,017,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Resona Asset Management Co. Ltd. increased its stake in Agilent Technologies by 6.2% in the 2nd quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock valued at $11,631,000 after buying an additional 5,767 shares during the last quarter. TrueMark Investments LLC acquired a new stake in shares of Agilent Technologies in the second quarter valued at about $1,999,000. Nuance Investments LLC raised its holdings in Agilent Technologies by 13.5% during the second quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock worth $9,523,000 after acquiring an additional 9,628 shares in the last quarter. Fenimore Asset Management Inc boosted its position in Agilent Technologies by 2.7% during the second quarter. Fenimore Asset Management Inc now owns 180,880 shares of the medical research company’s stock valued at $21,346,000 after purchasing an additional 4,823 shares during the last quarter. Finally, Godsey & Gibb Inc. grew its stake in Agilent Technologies by 19.8% in the second quarter. Godsey & Gibb Inc. now owns 166,664 shares of the medical research company’s stock valued at $19,668,000 after purchasing an additional 27,520 shares in the last quarter. Institutional investors own 87.41% of the company’s stock.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 911 shares of the business’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total value of $130,491.64. Following the completion of the sale, the chief executive officer directly owned 32,058 shares in the company, valued at $4,591,987.92. The trade was a 2.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the transaction, the vice president directly owned 31,846 shares in the company, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 16,401 shares of company stock valued at $2,468,962. 0.26% of the stock is currently owned by insiders.

Agilent Technologies Price Performance

Shares of A opened at $137.16 on Monday. The company’s 50-day moving average is $145.44 and its 200-day moving average is $130.16. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. The firm has a market capitalization of $38.89 billion, a PE ratio of 30.01, a PEG ratio of 3.98 and a beta of 1.27. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, beating analysts’ consensus estimates of $1.58 by $0.01. The business had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. Agilent Technologies’s quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.46 EPS. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Equities analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be paid a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date is Tuesday, January 6th. Agilent Technologies’s dividend payout ratio is 22.32%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on A. Rothschild Redb upgraded Agilent Technologies to a “strong-buy” rating in a research note on Wednesday, October 8th. TD Cowen upped their price target on shares of Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a research report on Tuesday, October 14th. Evercore ISI lifted their price objective on shares of Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research report on Tuesday, October 7th. UBS Group boosted their price objective on shares of Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a research note on Tuesday, November 25th. Finally, Barclays upgraded shares of Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $165.00 target price for the company in a research note on Monday, December 15th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $161.77.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.